Evidence-based Therapy in Vascular Surgery

Description:

 

This book is an introduction to quality initiative for vascular surgery and medicine. Originally published in German, the book is written by leading experts who utilise their professional expertise and insight to help raise the level of patient safety, quality of care, and training of junior vascular physicians. This books aims to bring together the best available current treatment and information, including recent guidelines, meta-analyses, and randomised trials to help put evidence-based therapeutic recommendations into practice. Innovative therapeutic treatment options are not currently incorporated within standard procedure, and this book will help physicians include these methods and create more individualised treatment.

 

Table of Contents:

 

Chapter 1: Extracranial Carotid Stenosis

1.1 Guidelines

1.1.1 European Society of Cardiology (ESC)

1.1.2 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/VM/SVS

1.1.3 American Heart Association/American Stroke Association

1.1.4 Screening for Asymptomatic Carotid Artery Stenosis: U.S. Preventive Services Task Force Reco

1.1.5 Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Caroti

1.1.5.1 Management of Moderate or Severe Carotid Stenosis

1.2 Results

1.2.1 Randomized Studies for CEA Versus CAS

1.2.2 Meta-analysis/Systematic Reviews for CEA Versus CAS

1.2.3 Registry Data CEA and CAS

1.2.4 Registry Data CEA

1.2.5 Registry Data CAS

1.3 Special Questions

1.3.1 Volume Outcome Relationship

1.3.2 Restenosis After CEA

1.3.3 Intraoperative Shunting During CEA

1.3.4 Patching During CEA

1.3.5 Eversion (ECEA) or Conventional (CCEA) Technique

1.3.6 Early Risk of Stroke After Cerebrovascular Event

1.3.7 Early Intervention After Neurological Event

1.3.8 CEA After Intravenous Thrombolysis for Acute Ischemic Stroke?

1.3.9 CEA and Coronary Bypass – Synchronous or Staged Approach?

1.3.10 Local or General Anesthesia in CEA?

1.3.11 Management of Asymptomatic Carotid Stenosis

1.4 Conclusions for Clinical Practice

References

Chapter 2: Distal Aortic Dissection Type Stanford B

2.1 Guidelines

2.1.1 American Heart Association (AHA)

2.1.2 European Society of Cardiology (ESC)

2.1.3 Society of Thoracic Surgeons Expert Consensus Document

2.1.4 Interdisciplinary Expert Consensus Document

2.2 Results

2.2.1 Acute Uncomplicated Type B Aortic Dissection

2.2.1.1 Best Medical Treatment

2.2.1.2 Best Medical Treatment and Endovascular Aortic Repair

2.2.2 Acute Complicated Aortic Dissections Type B

2.2.2.1 Endovascular and Open Repair

2.2.2.2 Clinical Studies and Case Series

2.2.2.3 Aortic Fenestration

2.2.3 Chronic Aortic Dissections Type B

2.2.3.1 Systematic Reviews

2.2.3.2 Randomized Study

2.2.3.3 Case Series

2.2.3.4 Registry Data

2.3 Conclusions for Clinical Practice

References

Chapter 3: Descending Thoracic Aortic (DTAA) and Thoracoabdominal Aortic Aneurysms (TAAA)

3.1 Guidelines

3.1.1 Surgical Indications

3.1.2 Endovascular Versus Open Surgical Approach

3.1.3 Spinal Cord Protection During Thoracic and Thoracoabdominal Aortic Surgery and Endovascular

3.2 Results

3.2.1 Descending Thoracic Aortic Aneurysms (DTAA)

3.2.1.1 Meta-analyses

3.2.1.2 Registry Data

3.2.1.3 Cost Analysis

3.2.1.4 Multicenter Study

3.2.2 Thoracic Abdominal Aortic Aneurysm (TAAA)

3.2.2.1 Endovascular vs Open Surgical Approach

3.2.2.2 Endovascular Repair

3.2.2.3 Hybrid Technique

3.2.2.4 Open Repair

3.2.3 Special Questions

3.2.3.1 Risk of Rupture and Growth Rates in TAA

3.3 Conclusions for Clinical Practice

References

Chapter 4: Abdominal Aortic Aneurysm (AAA)

4.1 Guidelines

4.1.1 Monitoring and Indication for Surgery

4.1.2 Cochrane Review

4.1.3 Screening

4.1.4 Management

4.2 Results

4.2.1 Screening

4.2.1.1 Systematic Reviews/Metaanalyses

4.2.1.2 Results

4.2.2 Intact AAA

4.2.2.1 Randomized Studies Comparing Open and Endovascular Repair

4.2.2.2 Meta-analyses for Open and Endovascular Repair

4.2.2.3 Registry Data

4.2.3 Ruptured AAA (rAAA)

4.2.3.1 EVAR vs. OR – Randomized Studies and Meta-analyses

4.2.3.2 Registry Data

4.2.4 Special Issues

4.2.4.1 AAA Treatment in Centres and Surgeon Specialization

4.2.4.2 Risk Stratification

4.2.4.3 EVAR – Totally Percutaneous Versus Standard Femoral Artery Access

4.2.4.4 Balloon Occlusion of the Aorta with rAAA

4.2.4.5 EVAR in Young Patients

4.2.4.6 Bowel Ischemia After AAA Repair

4.2.4.7 Reinforcement of Midline Laparotomies for AAA

4.2.4.8 Rupture Rates of Untreated Large AAA

4.3 Conclusions for Clinical Practice

References

Chapter 5: Renal Artery Stenosis

5.1 Guidelines

5.1.1 American College of Cardiology Foundation/American Heart Association

5.1.2 European Society of Cardiology (ESC)

5.1.3 Revascularization for Renal Artery Fibromuscular Dysplasia (FMD)

5.1.3.1 Scientific Statement from the American Heart Association

5.1.3.2 European Consensus on the Diagnosis and Management of Fibromuscular Dysplasia

5.1.4 Addendum

5.2 Results

5.2.1 Endovascular Therapy

5.2.1.1 Systematic Reviews/Meta-analyses

5.2.1.2 Randomized Studies

5.2.1.3 Uncontrolled Studies

5.2.2 Endovascular vs. Open Surgery for Treatment of RAS

5.2.2.1 Fibromuscular Dysplasia

5.2.2.2 Registry Data

5.3 Conclusions for Clinical Practice

References

Chapter 6: Visceral Artery Aneurysms (Including Renal Artery Aneurysms)

6.1 Guidelines

6.2 Results

6.2.1 Endovascular Repair

6.2.2 Open Repair

6.2.3 Endovascular and Open Repair

6.2.4 Special Issues

6.2.4.1 Incidence and Outcome of VAA and RAA

6.2.4.2 Renal Artery Aneurysms – Natural History

6.2.4.3 Splenic Artery Aneurysms – Rupture and Pregnancy

6.2.4.4 Laparoscopic Treatment of Splenic Artery Aneurysms

6.3 Conclusions for Clinical Practice

References

Chapter 7: Chronic Mesenteric (Intestinal) Ischemia

7.1 Clinical Diagnostics and Therapy/Medical Guidelines

7.1.1 American College of Cardiology Foundation/American Heart Association

7.1.2 European Society of Cardiology (ESC)

7.2 Results

7.2.1 Systematic Overview of Literature

7.2.2 Registry Data

7.2.3 Endovascular Therapy – Case Series

7.2.4 Endovascular Revascularization of the Superior Mesenteric Artery (SMA) and Celiac Artery 

7.2.5 Endovascular vs. Open Revascularization

7.2.6 Open Revascularization

7.3 Conclusions for Clinical Practice

References

Chapter 8: Intermittent Claudication

8.1 Treatment Indications/Guidelines

8.1.1 American College of Cardiology Foundation/American Heart Association

8.1.2 National Institute for Health and Care Excellence (NICE)

8.1.3 European Society of Cardiology (Tendera et al. 2011)

8.1.4 Society for Vascular Surgery Practice Guidelines (Conte et al. 2015)

8.1.5 Reporting Standards of the Society for Vascular Surgery (Stoner et al. 2016)

8.1.5.1 Claudication Reporting

8.1.5.2 Outcome Measures: Procedural

8.1.5.3 Outcome Measures: Disease Specific

8.2 Results

8.2.1 Exercise Training

8.2.1.1 Meta-analysis/Systematic Reviews

8.2.1.2 Studies

8.2.2 Endovascular Therapy

8.2.2.1 Meta-analyses/Systematic Reviews

8.2.2.2 Studies

8.2.3 Exercise Therapy and Endovascular Therapy

8.2.3.1 Meta-analysis/Systematic Reviews

8.2.3.2 Studies

8.2.4 Endovascular and Surgical Intervention

8.2.5 Antiplatelet Therapy After Endovascular Arterial Procedures

8.3 Conclusions for Clinical Practice

References

Chapter 9: Critical Limb Ischemia

9.1 Classification and Prognosis

9.2 Guidelines

9.2.1 American College of Cardiology Foundation (ACCF)/American Heart Association (AHA)

9.3 Objective Performance Goals (OPG) for Evaluating New Catheter-Based Treatments in CLI

9.4 Results

9.4.1 Endovascular Therapy

9.4.1.1 Endovascular Techniques

9.4.1.2 Studies and Registry Data

9.4.2 Surgical Intervention

9.4.2.1 Studies and Registry Data

9.4.2.2 Bypass Surgery Following Endovascular Intervention

9.4.2.3 Biological Bypass Material

9.4.2.4 Synthetic Bypass Grafts in CLI

9.4.2.5 Revascularisation in Patients with End-Stage Renal Disease

9.4.3 Comparison of Endovascular Versus Surgical Revascularisation

9.5 Conclusions for Clinical Practice

References

Chapter 10: Acute Limb Ischemia

10.1 Classification and Prognosis

10.2 Guidelines

10.2.1 TASC II Working Group

10.2.2 American College of Cardiology Foundation/American Heart Association

10.2.3 European Society of Cardiology

10.2.4 American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

10.3 Results

10.3.1 Systematic Reviews

10.3.2 Thrombolysis

10.3.2.1 Catheter-Directed Thrombolysis

10.3.2.2 Ultrasound-Accelerated Thrombolysis

10.3.2.3 Thrombolysis/Dosage

10.3.3 Percutaneous Endovascular Thrombosuction

10.3.4 Surgical Treatment

10.3.4.1 Acute Thrombembolectomy

10.3.4.2 Bypass Surgery

10.3.5 Registry Data on Treatment of ALI

10.3.6 Endovascular and Surgical Revascularisation in ALI

10.3.7 Specific Issues

10.4 Conclusions for Clinical Practice

References

Chapter 11: Popliteal Artery Aneurysm

11.1 Guidelines

11.2 Results

11.2.1 Meta-analysis and Systematic Overviews

11.2.2 Registry Data

11.2.3 Clinical Studies: OR

11.2.4 Clinical Studies: ER

11.2.5 Comparative Studies OR Versus ER

11.2.6 Special Issues

11.2.6.1 Thrombolysis for Acute Thrombosed PAA

11.2.6.2 Outcome in Women

11.2.6.3 Decision analysis Model for OR vs. ER

11.3 Conclusions for Clinical Practice

References

Chapter 12: Vascular Access for Hemodialysis

12.1 Guidelines

12.1.1 UK Renal Association

12.1.2 Society for Vascular Surgery

12.1.3 National Kidney Foundation (USA)

12.1.4 German Task Force Clinical Nephrology

12.2 Results

12.2.1 Meta-analyses/Systematic Reviews

12.2.1.1 Choice of Haemodialysis Access

12.2.1.2 Treatment of Thrombosed Dialysis Shunts

12.2.1.3 Preemptive Correction of Arteriovenous Access Stenosis

12.2.2 Registry Data

12.2.3 Clinical Studies

12.2.3.1 Choice of Vascular Access

12.2.3.2 Alternative Vascular Accesses

12.2.3.3 Vascular Access in Paediatrics

12.2.3.4 Prosthetic Arteriovenous Access

12.2.3.5 Endografts to Exclude Pseudoaneurysms

12.2.3.6 Percutaneous Interventions on Failing Arteriovenous Fistulas and Grafts

12.2.3.7 Access Induced Ischemia (Steal Syndrome)

12.3 Conclusions for Clinical Practice

References

Chapter 13: The Diabetic Foot

13.1 Guidelines

13.1.1 Society for Vascular Surgery (SVS)

13.1.2 International Working Group on the Diabetic Foot (IWGDF)

13.2 WIfI-Classification-System

13.3 Results

13.3.1 Revascularization

13.3.2 Prognosis

13.3.3 Risk of Amputation

13.3.4 Local Therapy

13.3.4.1 Wound Bed Preparation in the Treatment of Diabetic Ulcers

13.3.4.2 Dressing Products

13.3.4.3 Skin Substitutes

13.3.4.4 Negative Pressure Wound Therapy

13.3.4.5 Hyperbaric Oxygen Therapy

13.3.4.6 Platelet-Rich Plasma

13.3.4.7 Off-Loading Methods for Diabetic Foot Ulcers

13.3.5 Diabetic Foot Infection

13.3.6 Nerve Decompression

13.3.7 Tendon Lengthening and Fascia Release

13.4 Conclusions for Clinical Practice

References

Chapter 14: Varicose Veins

14.1 Guideline Recommendations

14.1.1 NICE

14.1.2 Society for Vascular Surgery (SVS) and the American Venous Forum (AVF)

14.1.3 European Society for Vascular Surgery (ESVS)

14.1.4 European Guidelines for Sclerotherapy

14.2 Results

14.2.1 Sclerotherapy

14.2.2 Endovenous Thermal Ablation

14.2.2.1 Meta-analyses and Systematic Reviews

14.2.2.2 Venous Leg Ulcers

14.2.2.3 Randomized Studies with Endovenous Laser Therapy

14.2.2.4 Studies with Endovenous Radiofrequency Ablation

14.2.2.5 Clinical Effectiveness and Cost-effectiveness of Minimally Invasive Techniques

14.2.3 Further Minimally Invasive Techniques

14.2.3.1 Steam Ablation

14.2.3.2 Mechano-chemical Ablation

14.2.3.3 Cyanoacrylate-Embolization

14.2.4 Compression Stockings as Initial Treatment Option for Varicose Veins

14.3 Conclusions for Clinical Practice

 

 

 

Springer

An aparitie	30 Mar 2017
Autor	E. Sebastian Debus,‎ Reinhart T. Grundmann
Dimensiuni	16.5 x 2.3 x 24.4 cm
Editura	Springer
Format	Hardback
ISBN	9783319471471
Limba	Engleza
Nr pag	285